COMMUNIQUÉS West-GlobeNewswire

Hyperion DeFi, Anchorage Digital, and HyperLend Together Announce the First Institutional Credit Facility on Hyperliquid
30/09/2026
Institutional Credit Layer on HyperEVM Secured by Collateral in Qualified Custody at a Federally Chartered Bank DALLAS, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “ [...]
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
30/09/2026
- Recently awarded patents have solidified Allarity’s strategy to leverage DRP to ensure the commercial exclusivity of stenoparib TARPON SPRINGS, Fla., September 30, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the [...]
CJ Biomaterials Secures BPI, TÜV AUSTRIA Certifications for New PHACT™ All-PHA Compound Designed for Home Compostable Cutlery
30/09/2026
PHACT™ CB0104A earned BPI Commercial and Home Compostable, TÜV AUSTRIA OK compost HOME & OK compost INDUSTRIAL Certifications New all-PHA compound is designed for cutlery, caps, enclosures, beauty packaging, and [...]
ALK expands strategic tablet supply partnership with Catalent
30/09/2026
Inside Information Agreement provides long-term expanded access to Catalent's fast-dissolving (Zydis ® ) tablet formulation technology. Supply robustness secured with prioritised manufacturing capacity increase of ~40% [...]
SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity
30/09/2026
RANCHO CORDOVA, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a comprehensive five-year, more than $200 million investment plan to expand and upgrade its U.S. development and manufacturing [...]
Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026
30/09/2026
NESS ZIONA, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced it will [...]
Inteleos Earns UN ECOSOC Status to Advance Quality Care Worldwide
30/09/2026
Special Consultative Status expands Inteleos’ ability to build health equity through global partners and policy ROCKVILLE, Md., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The United Nations Economic and Social Council (ECOSOC) [...]
FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees
30/09/2026
Silver Spring, Md., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced a broad, nationwide recruitment effort to expand the range of qualified voices and perspectives on its [...]
Peptides Canada, Operated by Growth Guys, Announces Research-Use Peptide Supply Services for Canadian Laboratories
30/09/2026
TORONTO, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Peptides Canada has announced the availability of research-use peptide materials through its online platform, providing Canadian laboratories and researchers with access to [...]
Native Path Collagen 2026: Launch Effective NativePath Collagen Peptides Dark Spots Bruising & Support for Skin, Hair, Joints & Bones Supplement Facts
30/09/2026
NativePath Collagen Peptides, a hydrolyzed Type I and III collagen supplement made from grass-fed bovine sources. Learn about its ingredients, formulation, and how collagen peptides are designed to complement daily [...]
UPDATE – Free Family Fun Night in Cedar Park: Ally Medical ER Ribbon Cutting
30/09/2026
EVENT UPDATE: Due to the flood watch in effect and the potential for severe weather, this event will be postponed . Please stay safe and keep an eye out for an updated date and time. The original release follows: CEDAR [...]
Flame Diet App Launches Personalized Anti-Inflammatory Diet
30/09/2026
Flame Diet App Turns a Short Quiz Into an Anti-Inflammatory Meal Plan and Light Workout Routine NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Flame Diet has launched a personalized anti-inflammatory diet and wellness app [...]
Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026
30/09/2026
In the Phase 3 open-label extension clinical trial (OLE), patients with moderate to severe acne received denifanstat for up to 52 weeks, including prior placebo patients Denifanstat showed progressive and sustained [...]
Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants
30/09/2026
FOSTER CITY, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting
30/09/2026
Data from Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial will be presented in a late-breaking oral presentation during Uveitis Subspecialty Day 2026 Post-hoc analyses of baseline characteristics and efficacy [...]
Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)
30/09/2026
BOSTON, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression
30/09/2026
DARPA states that the program, if successful, will fundamentally change the Standard of Care for Treatment Resistant Depression. The Military has recognized that current treatments for depression are not deployable in [...]
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
30/09/2026
New clearance to further simplify bedside EEG interpretation and enable more informed interventions for patients of all ages across multiple indications SUNNYVALE, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- CeriBell, [...]
Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO
30/09/2026
NASHVILLE, Tenn., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that 15 scientific abstracts featuring data [...]

Pages